Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Amylyx Pharmaceuticals, Inc.

Pharmaceutical Preparations · Cambridge, MA, United States

  1. PrincipalsCamille L BedrosianChief Medical OfficerGina MazzarielloChief Legal OfficerJames M FratesChief Financial Officerand 4 more
  2. CompanyAmylyx Pharmaceuticals, Inc.Cambridge, MA, United States
  3. Phone line+1 (617) 682-0917General business
Request a quote

Amylyx Pharmaceuticals, Inc. is an SEC-registered Nasdaq-listed company (ticker AMLX) classified under SIC 2834: Pharmaceutical Preparations.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions

People 7

Chief executive

Joshua B CohenCo-Chief Executive Officer
Justin B. KleeCo-Chief Executive Officer

Chair & board

George M Milne JrDirector (Board)
Karen FirestoneDirector (Board)

Finance

James M FratesChief Financial Officer

Legal

Gina MazzarielloChief Legal Officer
Everyone else on file (1)
Camille L BedrosianChief Medical Officer

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Camille L Bedrosian — Chief Medical Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Gina Mazzariello — Chief Legal Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. James M Frates — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Joshua B Cohen — Co-Chief Executive Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers